NERVGEN PHARMA CORP. Net Fee Amt
NERVGEN PHARMA CORP. (NGEN) had Net Fee Amt of $22.10 thousand as of 2026-05-26, per its F-10 filed 2026-05-26.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-05-26
- 2026-05-26: Net Fee Amt $22.10K.
- 2026-05-06: Net Fee Amt $1.53K.
| Period end | Net Fee Amt |
|---|---|
| 2026-05-26 | $22.10K F-10 · filed 2026-05-26 |
| 2026-05-06 | $1.53K S-8 · filed 2026-05-07 |